Every material Form 8-K Anterix Inc. has filed with the SEC since August 06, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Anterix's board authorized a new share repurchase program allowing the company to buy up to $250 million of its common stock on or before September 22, 2029. The program is set to begin September 22, 2026, after the previous program expires on September 21, 2026.
Authorized repurchase amount: up to $250 million of common stock
Program period: effective September 22, 2026, with repurchases allowed on or before September 22, 2029
Repurchases may be made in the open market or in privately negotiated transactions, including under Rule 10b5-1 plans
The company is not obligated to buy any particular amount, and the program may be suspended, discontinued or modified at any time
Anterix reported first quarter fiscal 2027 results for the three months ended June 30, 2026. Spectrum revenue rose to $2.0 million from $1.4 million a year earlier, but net income fell to $240,000, or $0.01 per diluted share, from $25.2 million, or $1.35, as the prior-year period included a $33.9 million gain on exchange of intangible assets. The company reported no debt and $116.0 million in cash at June 30, 2026.
Net income was $240,000 ($0.01 per diluted share), compared with $25,180,000 ($1.35 per diluted share) a year earlier.
Cash and cash equivalents were $116.0 million at June 30, 2026, with no debt; $226.7 million remained under the share repurchase program, and there was no repurchase activity in the quarter.
Management will hold a business update call at 9:00 A.M. ET on August 12, 2026.
At its August 4, 2026 annual meeting, Anterix stockholders approved Amendment No. 2 to the 2023 Stock Plan, which adds 1.0 million shares of common stock available for issuance, and elected seven directors. Stockholders also approved the advisory say-on-pay vote and ratified Deloitte & Touche LLP as auditor, so the plan change adds share capacity for future equity awards.
Plan amendment approved with 13,558,280 votes for and 1,099,125 against; it adds 1.0 million shares to the 2023 Stock Plan
Seven directors elected, including Jeffrey A. Altman and Mahvash Yazdi, to serve until the 2027 Annual Meeting
Advisory vote on executive compensation approved with 14,641,617 votes for and 15,894 against; stockholders chose a one-year frequency for future votes
Deloitte & Touche LLP ratified for the fiscal year ending March 31, 2027; quorum was about 90.06% of eligible shares
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Anterix Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →